Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The unusual source weight-cap threshold and bolus maximum are preserved, not recalculated.
Check source scope before reading a dose
GlobalRPh RX List - INTEGRILIN
Product / population
Adult intravenous eptifibatide for ACS/PCI; infusion adjustment, not a complete antithrombotic order set.
Renal method
Cockcroft-Gault CrCl in mL/min.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
A renal infusion reduction is not a dialysis allowance
The infusion adjustment concerns low clearance in eligible adults. Dialysis dependency appears separately in the contraindications.
What to reconcile: Check dialysis status and bleeding contraindications before applying the infusion reduction. Retain bolus, duration and co-antithrombotic rules from the same protocol.
GlobalRPh-hosted RX List · Adult intravenous eptifibatide for ACS/PCI; infusion adjustment, not a complete antithrombotic order set.
Renal method: Cockcroft-Gault CrCl in mL/min. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
At CrCl below 50 mL/min, reduce the infusion to 1 mcg/kg/min. The indication-specific 180 mcg/kg bolus instructions are not reduced by this renal rule; PCI includes its specified second bolus. Dialysis dependency is a contraindication, not an invitation to extend the low-clearance infusion band. Bleeding risk, other antithrombotics, platelet counts and full treatment-duration instructions require separate review.
RDM43-rxlist-eptifibatide-a2b347b1fc-C1 · Source locator: Selected Dosage / Renal Impairment / Warnings sections; see source-specific qualifications in this summary.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.